The effect of hepatoheal tablet on non alcoholic fatty liver - Trial IRCT2014042612438N6
Access comprehensive clinical trial information for IRCT2014042612438N6 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by Barij Research Center of Medicinal Herbs and is currently Completed. The study focuses on Nonalcoholic fatty liver disease (NAFLD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT2014042612438N6
Phase 2/3
Completed
drug
Trial Details
Iranian Registry Of Clinical Trial • IRCT2014042612438N6
The effect of hepatoheal tablet on non alcoholic fatty liver
The effect of hepatoheal tablet on liver enzymes of patients with non alcoholic fatty liver and its comparison with vitamin E
Study Focus
Sponsor & Location
Barij Research Center of Medicinal Herbs
Iran
Timeline & Enrollment
Phase 2/3
May 22, 2014
N/A
ICD-10 Classifications
Liver disease, unspecified
Inflammatory liver disease, unspecified
Alcoholic liver disease, unspecified
Alcoholic fatty liver
Toxic liver disease, unspecified
Data Source
Iranian Registry Of Clinical Trial
IRCT2014042612438N6
Non-Device Trial